ESR1 and breast carcinoma: Furthermore, the Breast Cancer Consensus Subtypes (BCCS) have classified tumors based on gene expression, revealing that estrogen receptor-positive (ER+) subtypes like PCS1 and PCS4 are associated with better prognoses, whereas subtypes like PCS2 and PCS3 are linked to poor outcomes [3].